uPAR Targeted Radionuclide Therapy with 177Lu-DOTA-AE105 Inhibits Dissemination of Metastatic Prostate Cancer
Year: 2014
Type: article
Source: Molecular Pharmaceutics
DOI: 10.1021/mp500177c
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk Fonden
Award: G7201597523
OpenAlex ID: W2321810802
